You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Epilepsy Therapeutic Market Professional Research Report 2021-2027

Market Analysis and Insights: Global Epilepsy Therapeutic Market
The research report studies the Epilepsy Therapeutic market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Epilepsy Therapeutic market size is projected to reach US$ 5227.3 million by 2027, from US$ 4076.9 million in 2020, at a CAGR of 3.2% during 2021-2027.
Global Epilepsy Therapeutic Scope and Segment
The global Epilepsy Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epilepsy Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
First Generation
Second Generation
by Application, this report covers the following segments
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Epilepsy Therapeutic market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Epilepsy Therapeutic key players in this market include:
Abbott Laboratories
GlaxoSmithKline Plc
UCB
Cephalon
Johnson & Johnson
Pfizer
Novartis AG
Abbvie
Janssen Pharmaceuticals
Sunovion Pharmaceuticals
Bausch Health
Sanofi S.A
Takeda
Eisai
F. Hoffmann-La Roche
1 Market Overview of Epilepsy Therapeutic
1.1 Epilepsy Therapeutic Market Overview
1.1.1 Epilepsy Therapeutic Product Scope
1.1.2 Epilepsy Therapeutic Market Status and Outlook
1.2 Global Epilepsy Therapeutic Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Epilepsy Therapeutic Market Size by Region (2016-2027)
1.4 Global Epilepsy Therapeutic Historic Market Size by Region (2016-2021)
1.5 Global Epilepsy Therapeutic Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Epilepsy Therapeutic Market Size (2016-2027)
1.6.1 North America Epilepsy Therapeutic Market Size (2016-2027)
1.6.2 Europe Epilepsy Therapeutic Market Size (2016-2027)
1.6.3 Asia-Pacific Epilepsy Therapeutic Market Size (2016-2027)
1.6.4 Latin America Epilepsy Therapeutic Market Size (2016-2027)
1.6.5 Middle East & Africa Epilepsy Therapeutic Market Size (2016-2027)

2 Epilepsy Therapeutic Market Overview by Type
2.1 Global Epilepsy Therapeutic Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Epilepsy Therapeutic Historic Market Size by Type (2016-2021)
2.3 Global Epilepsy Therapeutic Forecasted Market Size by Type (2022-2027)
2.4 First Generation
2.5 Second Generation

3 Epilepsy Therapeutic Market Overview by Application
3.1 Global Epilepsy Therapeutic Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Epilepsy Therapeutic Historic Market Size by Application (2016-2021)
3.3 Global Epilepsy Therapeutic Forecasted Market Size by Application (2022-2027)
3.4 Hospital Pharmacies
3.5 Retail Pharmacies
3.6 Online Pharmacies

4 Epilepsy Therapeutic Competition Analysis by Players
4.1 Global Epilepsy Therapeutic Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Epilepsy Therapeutic as of 2020)
4.3 Date of Key Players Enter into Epilepsy Therapeutic Market
4.4 Global Top Players Epilepsy Therapeutic Headquarters and Area Served
4.5 Key Players Epilepsy Therapeutic Product Solution and Service
4.6 Competitive Status
4.6.1 Epilepsy Therapeutic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Epilepsy Therapeutic Products, Services and Solutions
5.1.4 Abbott Laboratories Epilepsy Therapeutic Revenue (US$ Million) & (2016-2021)
5.1.5 Abbott Laboratories Recent Developments
5.2 GlaxoSmithKline Plc
5.2.1 GlaxoSmithKline Plc Profile
5.2.2 GlaxoSmithKline Plc Main Business
5.2.3 GlaxoSmithKline Plc Epilepsy Therapeutic Products, Services and Solutions
5.2.4 GlaxoSmithKline Plc Epilepsy Therapeutic Revenue (US$ Million) & (2016-2021)
5.2.5 GlaxoSmithKline Plc Recent Developments
5.3 UCB
5.3.1 UCB Profile
5.3.2 UCB Main Business
5.3.3 UCB Epilepsy Therapeutic Products, Services and Solutions
5.3.4 UCB Epilepsy Therapeutic Revenue (US$ Million) & (2016-2021)
5.3.5 Cephalon Recent Developments
5.4 Cephalon
5.4.1 Cephalon Profile
5.4.2 Cephalon Main Business
5.4.3 Cephalon Epilepsy Therapeutic Products, Services and Solutions
5.4.4 Cephalon Epilepsy Therapeutic Revenue (US$ Million) & (2016-2021)
5.4.5 Cephalon Recent Developments
5.5 Johnson & Johnson
5.5.1 Johnson & Johnson Profile
5.5.2 Johnson & Johnson Main Business
5.5.3 Johnson & Johnson Epilepsy Therapeutic Products, Services and Solutions
5.5.4 Johnson & Johnson Epilepsy Therapeutic Revenue (US$ Million) & (2016-2021)
5.5.5 Johnson & Johnson Recent Developments
5.6 Pfizer
5.6.1 Pfizer Profile
5.6.2 Pfizer Main Business
5.6.3 Pfizer Epilepsy Therapeutic Products, Services and Solutions
5.6.4 Pfizer Epilepsy Therapeutic Revenue (US$ Million) & (2016-2021)
5.6.5 Pfizer Recent Developments
5.7 Novartis AG
5.7.1 Novartis AG Profile
5.7.2 Novartis AG Main Business
5.7.3 Novartis AG Epilepsy Therapeutic Products, Services and Solutions
5.7.4 Novartis AG Epilepsy Therapeutic Revenue (US$ Million) & (2016-2021)
5.7.5 Novartis AG Recent Developments
5.8 Abbvie
5.8.1 Abbvie Profile
5.8.2 Abbvie Main Business
5.8.3 Abbvie Epilepsy Therapeutic Products, Services and Solutions
5.8.4 Abbvie Epilepsy Therapeutic Revenue (US$ Million) & (2016-2021)
5.8.5 Abbvie Recent Developments
5.9 Janssen Pharmaceuticals
5.9.1 Janssen Pharmaceuticals Profile
5.9.2 Janssen Pharmaceuticals Main Business
5.9.3 Janssen Pharmaceuticals Epilepsy Therapeutic Products, Services and Solutions
5.9.4 Janssen Pharmaceuticals Epilepsy Therapeutic Revenue (US$ Million) & (2016-2021)
5.9.5 Janssen Pharmaceuticals Recent Developments
5.10 Sunovion Pharmaceuticals
5.10.1 Sunovion Pharmaceuticals Profile
5.10.2 Sunovion Pharmaceuticals Main Business
5.10.3 Sunovion Pharmaceuticals Epilepsy Therapeutic Products, Services and Solutions
5.10.4 Sunovion Pharmaceuticals Epilepsy Therapeutic Revenue (US$ Million) & (2016-2021)
5.10.5 Sunovion Pharmaceuticals Recent Developments
5.11 Bausch Health
5.11.1 Bausch Health Profile
5.11.2 Bausch Health Main Business
5.11.3 Bausch Health Epilepsy Therapeutic Products, Services and Solutions
5.11.4 Bausch Health Epilepsy Therapeutic Revenue (US$ Million) & (2016-2021)
5.11.5 Bausch Health Recent Developments
5.12 Sanofi S.A
5.12.1 Sanofi S.A Profile
5.12.2 Sanofi S.A Main Business
5.12.3 Sanofi S.A Epilepsy Therapeutic Products, Services and Solutions
5.12.4 Sanofi S.A Epilepsy Therapeutic Revenue (US$ Million) & (2016-2021)
5.12.5 Sanofi S.A Recent Developments
5.13 Takeda
5.13.1 Takeda Profile
5.13.2 Takeda Main Business
5.13.3 Takeda Epilepsy Therapeutic Products, Services and Solutions
5.13.4 Takeda Epilepsy Therapeutic Revenue (US$ Million) & (2016-2021)
5.13.5 Takeda Recent Developments
5.14 Eisai
5.14.1 Eisai Profile
5.14.2 Eisai Main Business
5.14.3 Eisai Epilepsy Therapeutic Products, Services and Solutions
5.14.4 Eisai Epilepsy Therapeutic Revenue (US$ Million) & (2016-2021)
5.14.5 Eisai Recent Developments
5.15 F. Hoffmann-La Roche
5.15.1 F. Hoffmann-La Roche Profile
5.15.2 F. Hoffmann-La Roche Main Business
5.15.3 F. Hoffmann-La Roche Epilepsy Therapeutic Products, Services and Solutions
5.15.4 F. Hoffmann-La Roche Epilepsy Therapeutic Revenue (US$ Million) & (2016-2021)
5.15.5 F. Hoffmann-La Roche Recent Developments

6 North America
6.1 North America Epilepsy Therapeutic Market Size by Country (2016-2027)
6.2 United States
6.3 Canada

7 Europe
7.1 Europe Epilepsy Therapeutic Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe

8 Asia-Pacific
8.1 Asia-Pacific Epilepsy Therapeutic Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific

9 Latin America
9.1 Latin America Epilepsy Therapeutic Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America

10 Middle East & Africa
10.1 Middle East & Africa Epilepsy Therapeutic Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa

11 Epilepsy Therapeutic Market Dynamics
11.1 Epilepsy Therapeutic Industry Trends
11.2 Epilepsy Therapeutic Market Drivers
11.3 Epilepsy Therapeutic Market Challenges
11.4 Epilepsy Therapeutic Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
  • FORMAT: PDF
  • PUBLISHED DATE: May, 2021
  • NO OF PAGES: 125